Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date
Vincent Chau, Marijo Bilusic Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USACorrespondence: Marijo Bilusic Tel +1-301-765-4457Fax +1-240-541-4548Email marijo.bilusic@nih.govAbstract: Over the last 18 mon...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2020-08-01
|
| Σειρά: | Cancer Management and Research |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.dovepress.com/pembrolizumab-in-combination-with-axitinib-as-first-line-treatment-for-peer-reviewed-article-CMAR |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|